Mariner, LLC Eli Lilly & CO Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mariner, LLC holds 548,765 shares of LLY stock, worth $427 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

548,765

Previous 538,037 1.99%

Holding current value

$427 Million

Previous $487 Million 0.2%

% of portfolio

0.87%

Previous 0.95%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $8.28 Million - $10.3 Million	10,728 Added 1.99%	548,765 $486 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $14.2 Million - $17.8 Million	19,570 Added 3.77%	538,037 $487 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $19.5 Million - $26.1 Million	-33,000 Reduced 5.98%	518,467 $403 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $13.7 Million - $16.2 Million	26,165 Added 4.98%	551,467 $321 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $9.69 Million - $13.4 Million	22,293 Added 4.43%	525,302 $282 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $3.51 Million - $4.7 Million	-10,014 Reduced 1.95%	503,009 $236 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $12.4 Million - $14.5 Million	39,849 Added 8.42%	513,023 $176 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $9.41 Million - $11 Million	29,260 Added 6.59%	473,174 $173 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $4.83 Million - $5.51 Million	16,297 Added 3.81%	443,914 $144 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $12.7 Million - $15 Million	45,727 Added 11.97%	427,617 $139 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $7.16 Million - $8.89 Million	-30,497 Reduced 7.4%	381,890 $109 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $9.16 Million - $11.4 Million	40,743 Added 10.96%	412,387 $114 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $4.47 Million - $5.5 Million	20,152 Added 5.73%	371,644 $85.9 Million
Q2 2021 Aug 24, 2021	BUY	$180.55 - $233.54 $7.98 Million - $10.3 Million	44,210 Added 14.39%	351,492 $80.7 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $3.27 Million - $4.24 Million	19,921 Added 6.93%	307,282 $57.4 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $7.06 Million - $9.34 Million	54,104 Added 23.2%	287,361 $48.5 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $3.26 Million - $3.77 Million	22,301 Added 10.57%	233,257 $34.5 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $2.31 Million - $2.78 Million	16,960 Added 8.74%	210,956 $34.6 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $410,603 - $508,210	3,449 Added 1.81%	193,996 $26.9 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $2.99 Million - $3.7 Million	27,926 Added 17.17%	190,547 $25 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $1.16 Million - $1.26 Million	10,872 Added 7.16%	162,621 $18.2 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $287,832 - $335,973	-2,598 Reduced 1.68%	151,749 $16.8 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $105,410 - $124,075	947 Added 0.62%	154,347 $20 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $7.32 Million - $8.2 Million	69,096 Added 81.96%	153,400 $17.7 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $762,436 - $952,912	8,880 Added 11.77%	84,304 $9.05 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $1.16 Million - $1.33 Million	15,291 Added 25.43%	75,424 $6.44 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $1.03 Million - $1.22 Million	13,908 Added 30.09%	60,133 $4.65 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $914,532 - $980,940	11,161 Added 31.83%	46,225 $3.9 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.7 Million - $3 Million	35,064	35,064 $3 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account